Document Detail


Diagnostic transcranial ultrasound perfusion-imaging at 2.5 MHz does not affect the blood-brain barrier.
MedLine Citation:
PMID:  17854981     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
The purpose was to assess whether standard ultrasound (US) perfusion-imaging by means of contrast-enhanced transcranial color-coded sonography (TCCS) affects the blood-brain barrier (BBB) in patients with small-vessel disease (SVD). One week after a screening MRI to exclude a preexisting BBB disruption, unilateral TCCS phase inversion harmonic imaging (PIHI) was performed in an axial diencephalic plane after intravenous bolus application of 2.5 mL SonoVue (IGEA, Bracco, Italy). Magnetic resonance imaging (MRI) was performed immediately after US. In five patients, PIHI was performed applying a mean mechanical index (MI) of 0.7 +/- 0.1 for a time period of 2.5 min. MRI was started 12 +/- 2 min after US contrast injection. Comparisons of initial and post-US MRI by four blinded readers did not show any signs of BBB disruption. It is concluded that standard contrast-enhanced US perfusion imaging in patients with SVD did not lead to MRI-detectable BBB changes. This gives further evidence for safety of diagnostic US. Future investigations with larger sample sizes and higher-field MRI might give further insights into potential bioeffects of diagnostic, as well as therapeutic, contrast-enhanced transcranial US.
Authors:
Gerhard J Jungehulsing; Peter Brunecker; Christian H Nolte; Jochen B Fiebach; Claudia Kunze; Florian Doepp; Arno Villringer; Stephan J Schreiber
Publication Detail:
Type:  Journal Article     Date:  2007-09-14
Journal Detail:
Title:  Ultrasound in medicine & biology     Volume:  34     ISSN:  0301-5629     ISO Abbreviation:  Ultrasound Med Biol     Publication Date:  2008 Jan 
Date Detail:
Created Date:  2007-12-18     Completed Date:  2008-04-30     Revised Date:  -    
Medline Journal Info:
Nlm Unique ID:  0410553     Medline TA:  Ultrasound Med Biol     Country:  England    
Other Details:
Languages:  eng     Pagination:  147-50     Citation Subset:  IM    
Affiliation:
Department of Neurology and Berlin Neuroimaging Center Berlin, Charité, Germany. jan.jungehuelsing@charite.de
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
Adult
Aged
Blood-Brain Barrier*
Cerebral Infarction / physiopathology,  ultrasonography*
Contrast Media
Humans
Magnetic Resonance Imaging
Middle Aged
Phospholipids / diagnostic use
Sulfur Hexafluoride / diagnostic use
Thalamus / blood supply
Time Factors
Ultrasonography, Doppler, Color / adverse effects,  methods
Ultrasonography, Doppler, Transcranial / adverse effects*,  methods
Chemical
Reg. No./Substance:
0/Contrast Media; 0/Phospholipids; 0/contrast agent BR1; 2551-62-4/Sulfur Hexafluoride

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Real-time myocardial contrast echocardiography for assessing perfusion and function in healthy and i...
Next Document:  Changes in circulating immunosuppressive cytokine levels of cancer patients after high intensity foc...